Neurogene
NGNE
NGNE
81 hedge funds and large institutions have $49.7M invested in Neurogene in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 26
58% less capital invested
Capital invested by funds: $119M → $49.7M (-$69M)
Holders
81
Holding in Top 10
–
Calls
$337K
Puts
$246K
Top Buyers
| 1 | +$861K | |
| 2 | +$800K | |
| 3 | +$764K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$403K |
| 5 |
D.E. Shaw & Co
New York
|
+$205K |
Top Sellers
| 1 | -$4.15M | |
| 2 | -$1.08M | |
| 3 | -$601K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$484K |
| 5 |
JPMorgan Chase & Co
New York
|
-$278K |